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Deep venous thrombosis (DVT) of the lower
extremity and pulmonary embolism are common
complications resulting from prolonged periods of
bed rest or immobilization of the limbs. The inci-
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Purpose: External pneumatic compression (EPC) is an effective means of prophylaxis
against deep venous thrombosis. However, its mechanism remains poorly understood.
Understanding of the biological consequences of EPC is an important goal for optimiz-
ing performance of the EPC-generating device and providing guidance for clinical use.
We present a new in vitro cell culture system (Venous Flow Simulator) that simulates
blood flow and vessel collapse conditions during EPC, and we examine the influence of
these factors on endothelial cell (EC) fibrinolytic activity and vasomotor function.
Methods: An in vitro cell culture system was designed to replicate the hemodynamic shear
stress and vessel wall strain associated with induced blood flow during different modes of
EPC. Human umbilical vein endothelial cells were cultured in the system and subjected to
intermittent flow, vessel collapse, or a combination of the two. The biologic response was
assessed through changes in EC morphology and the expression of fibrinolytic factors tis-
sue plasminogen activator, plasminogen activator inhibitor type 1, profibrinolytic recep-
tor (annexin II), and vasomotor factors endothelial nitric oxide synthase and endothe-
lin–1.
Results: The cells remained attached and viable after being subjected to intermittent pul-
satile flow (F) and tube compression (C). In F and F + C, cells aligned in the direction of
flow after 6 hours. Northern blot analysis of messenger RNA shows that there is an
upregulation of tissue plasminogen activator expression (1.95 ± 0.19 in F and 2.45 ±
0.46 in FC) and endothelial nitric oxide synthase expression (2.08 ± 0.25 in F and 2.11
± 0.21 in FC). Plasminogen activator inhibitor type 1, annexin II, and endothelin 1 show
no significant change under any experimental conditions. The results also show that pul-
satile flow, more than vessel compression, influences EC morphology and function.
Conclusion: Effects on ECs of intermittent flow and vessel collapse, either individually
or simultaneously, were simulated with an in vitro system of new design. Initial results
show that intermittent flow associated with EPC upregulates EC fibrinolytic potential
and influences factors altering vasomotor tone. The system will facilitate future studies
of EC function during EPC. (J Vasc Surg 2000;32:977-87.)
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dence of DVT in trauma has been found to be 65%
in autopsy studies1 and 58% in patients studied with
venography.2 Furthermore, DVT accounts for peri-
operative morbidity and death in up to 30% of
orthopedic, trauma, and neurosurgical procedures
and has a significant morbidity in all aspects of sur-
gical and oncologic care.3
The prevalence of DVT is sufficiently high that
prophylactic procedures are typically used in patients
considered to be at risk. There are basically two
methods of prevention: pharmacologic (eg, heparin
and warfarin) and mechanical (eg, elastic stockings,
external pneumatic compression [EPC], and early
ambulation).4 Systemic anticoagulants can be effec-
tive but are often contraindicated in situations such
as major trauma and neurologic and radical pelvic
surgery where risk of hemorrhage is of particular
concern. Of the mechanical interventions, the most
effective method of prophylaxis against DVT is
EPC. Intermittent pneumatic compression devices
compress the leg for a few seconds of each minute.
The compression collapses the veins, which increas-
es venous blood flow during the period of the pulse.
Compared with traditional anticoagulant therapies,
EPC lessens the risk of bleeding and can be used
during surgery and the immediate recovery phase
during which systemic anticoagulant therapy is inap-
propriate. EPC has become widely favored because
of its high success rate and its ability to replicate the
body’s normal antithrombotic mechanisms. It has
been shown to be as effective in preventing DVT as
the leading pharmacologic agents in abdominal
surgery and neurosurgery and is highly effective
after various orthopedic procedures.5-8
Despite its wide acceptance as an effective means
of prophylaxis against DVT, the mechanism by
which incidence is reduced remains poorly under-
stood. Furthermore, although previous studies have
identified optimal compression conditions in terms
of hemodynamic factors,9,10 the biological correlates
of various modes of compression are still unknown.
It is known from in vitro studies that shear stress11,12
and cyclic strain13 can influence the release of tissue
plasminogen activator (t-PA) and its gene expression.
t-PA, one of the most important factors in the fibri-
nolytic system, converts plasminogen to active plas-
min, which dissolves fibrin and prevents thrombus
formation. These mechanical factors also regulate
expression of endothelial nitric oxide synthase
(eNOS),14,15 the enzyme involved in the synthesis of
nitric oxide that causes vasodilation and inhibits
platelet aggregation. Thus, to establish optimal pro-
tection from DVT requires that both hemodynamic
factors and factors relating to the prothrombotic,
fibrinolytic, and vasomotor systems be considered.
In this study we present a new in vitro flow sys-
tem that can be used to examine the effect of flow
conditions existing in vitro during EPC on function
in an endothelial monolayer. Specifically, the effects
of pulsed flow and partial vessel collapse occurring
on a 1-minute cycle are considered. The biologic
response is assessed through changes in cell mor-
phology, the expression of fibrinolytic factors, and
its vasomotor functions.
MATERIALS AND METHODS
Development of the Venous Flow Simulator.
An in vitro cell culture system, the Venous Flow
Simulator (VFS), was designed to replicate the
hemodynamic shear stress and vessel wall strain
associated with induced blood flow during different
modes of EPC. Although the mechanical forces on
the endothelium are quite complex and the vessels
at different locations experience different flows,
shear stresses, and strains,16 there are two hemody-
namic mechanisms that are thought to regulate
endothelial thrombogenicity and vasomotor tone:
fluid shear stress and mechanical deformation of the
vessel wall.11-15 The VFS is designed to simulate dif-
ferent levels of shear stress and vessel collapse indi-
vidually or simultaneously.
For this purpose, four completely independent
flow circuits are provided in the VFS to produce var-
ious combinations of conditions of flow (pulsatile or
a slow, steady perfusion) and collapse. Conditions in
each of the four flow circuits and the range of con-
ditions provided by each are indicated in Table I.
Physical description and characteristics of the
Table I. Conditions in each of the four flow circuits
Condition Abbreviation Flow rate Silastic tube
Control Cntrl Steady perfusion of 3 mL/min None
Pulsatile flow only F Intermittent pulsed flow (0-12.5 mL/s) None
Compression only C Steady perfusion of 3 mL/min 50% compression
Pulsatile flow + compression FC Intermittent pulsed flow (0-12.5 mL/s) 50% compression
Venous Flow Simulator. A schematic of the system is
shown in Fig 1, A. The Silastic tubes in which the
monolayer of human umbilical vein endothelial cells is
cultured are mounted inside two plexiglass chambers
as shown in the diagram. One of the chambers (Fig 1,
B), for circuits C and FC (Table I), has a pusher plate
attached to a bellows. The bellows can be periodically
inflated by an air pump to push the plate downward
and compress the tubes. An adjustable pin inserted
through the bottom of the tube holder limits dis-
placement of the plate to control the extent to which
the tube is collapsed. The other chamber, for circuits
JOURNAL OF VASCULAR SURGERY
Volume 32, Number 5 Dai et al 979
Fig 1. A, Schematic drawing of VFS. Four totally independent flow circuits are shown, corresponding
to the four cases in Table I. The air pump simultaneously drives the pulsed flow and the bellows to pro-
duce collapse. The reservoirs upstream of the test chambers are maintained at the proper carbon diox-
ide partial pressures. B, Test chamber used to produce tube compression. Air inflates the bellows, dri-
ving down the pusher plate to a position determined by small pegs inserted through bottom to desired
level. Inlet and outlet are designed to minimize flow disturbance.
A
B
Control and F (Table I), is identical to the first except
that it lacks the pusher plate and bellows because the
two tubes in it are not compressed. The cell culture
medium is driven by either the air pump for circuits F
and FC or the steady-flow perfusion pump for Control
and C. The air pump (adapted from Aircast Venaflow,
Aircast, Inc, Summit, NJ) operates to produce a short
period (4 seconds) of pressure in the air space above
the medium contained in a reservoir upstream of the
test chambers, followed by a rest period of 56 seconds.
The flow rate is controlled by a combination of the
applied pressure and the flow resistance upstream of
the test chamber. This produces a short period of high
flow through the tubes containing the cultured cells
alternating with a much longer period of zero flow,
which is intended to mimic the application of external
compression to the lower leg. Check valves located
upstream and downstream of the test chamber ensure
that the medium flows unidirectionally. The air pump
has two individually controlled outputs: one is used to
push the plate and the other to drive the pulsatile flow.
The combination of tube compression and flow type
leads to the four test groups indicated in Table I. All
timing and pressures are under computer control and
may be adjusted to any desired value within the ranges
specified in the table.
Each group is in its own independent flow loop
that provides a sterile nourishing environment and
also allows sampling of the media for biochemical
assay. The entire system (except air pump and flow
meter) is placed inside an incubator to maintain an
environment with a constant temperature (37°C).
Gas from the incubator (with proper carbon dioxide
content) is used to maintain proper gas tensions in
the medium. Time-varying flow rates are continuous-
ly monitored with a transit time ultrasonic flowmeter
(Model T109R; Transonic Systems, Ithaca, NY). At
the same time, pressure upstream of the test section is
monitored with a pressure transducer (Model 2200S;
Gould Inc, Cleveland, Ohio). Both signals were digi-
tized with a data acquisition system (DAQ-516;
National Instruments Inc, Austin, Tex) and stored for
later processing on computer (Apple G3 PowerBook:
Apple Computer, Inc, Cupertino, Calif).
Fabrication and measurement techniques used to
produce the silicone rubber tubes have been devel-
oped in our laboratory previously and have been
shown to support attachment, growth, and differen-
tiation of endothelial cells (ECs).17,18 The diameter,
thickness, and compliance of the tube can be
achieved to mimic those observed in human arteries
and veins.17 In the VFS, the properties of tubes are
chosen to mimic human saphenous vein (Table II).
Timing and pulsatile flow rate are also selected to fall
in the range of those predicted to occur in the deep
veins of the lower leg during the use of a typical
commercial pneumatic compression device.
Experimental design. The characteristics of
venous blood flow in vivo and the mechanical forces
and strains produced by EPC were considered when
establishing the experimental protocol. In vivo, the
endothelium is subjected to a complex time-depen-
dent and spatially dependent stress. In a typical EPC
setting, the veins experience a period of relatively
low flow (the refilling phase), followed by a short
period of high-flow during compression. Vessels
proximal to the compression zone (eg, the femoral
vein) experience a surge of flow with each compres-
sion, accompanied by a slight dilation due to the
increased internal pressure. Vessels beneath the cuff
experience less flow augmentation, but the flow
speeds are increased by partial venous collapse due
to compression. With a computational model we
have previously simulated the conditions occurring
during EPC and thereby produced estimates of flow
rates, degree of vessel collapse, and wall shear stress
throughout the venous network of the lower
extremity.16 Although the simulation is complicated,
several features that relate to the flow and vessel
strain can be identified that are common to most
veins. In all cases, flow remains low, near zero for the
entire period of vessel refilling. All vessels experience
a brief period of elevated flow during the compres-
sion phase. Vessels in the region beneath the com-
pression cuff also undergo some degree of collapse.
With these features in mind, the following factors
were identified that might potentially alter fibri-
nolytic and vasomotor functions and will be repro-
duced in experiments with VFS.
1. Elevated levels of shear stress. It has been found16
that during EPC, the endothelium experiences a
wide range of shear stress. These levels depend on
location within the venous network and the com-
pression modes. Shear stress can attain values as
high as 150 dyne/cm2 (near knee). Shear stress is
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Table II. Comparative compliance of human saphe-
nous vein and Silastic tube
Human saphenous vein Silastic tube
Compliance 4.5 ± 0.717 4.6 ± 0.5
(%/mm Hg × 10–2)
Diameter (mm) 4-719 5
Thickness (mm) 0.2-0.519 0.5
determined by a combination of flow rate and
vessel collapse during the compression phase.
2. Vessel wall strain. Veins beneath the compression
cuff collapse, whereas those proximal to it dis-
tend during the compression phase. Strains rang-
ing up to 20% have been predicted.16 Vessel col-
lapse is accomplished by means of a pusher plate.
The distance between the plate and the lower
rigid support determine the degree of vessel col-
lapse in any given experiment.
Fluid-induced shear stress on cultured ECs can
be completely and accurately assessed with analysis
of the flow using Womersley’s theory20 from the
measured pressure and flow rate data.20 With steady
flows, shear stress can be simply calculated on the
basis of the assumption of Poiseuille flow,
τ = 
3
π
2
D
µ
3
Q

where µ is viscosity, Q is flow rate, and D is tube
diameter.
Wall strain at the level of the endothelium can be
calculated on the basis of computed deformations of
the Silastic tube with ABAQUS. This is a Finite
Element Analysis software package (Version 5.2;
HKS, Inc Pawtucket, RI).
Establishment of Venous Flow Simulator cell
cultures. ECs from human umbilical veins were iso-
lated as previously described,21 with enzymatic treat-
ment (0.1% collagenase [CLS II; Worthington,
Frechold, NJ] and 0.5% human serum albumen
[Fraction V; Sigma Chemical Co, St Louis, Mo]).
Primary cultures were established, maintained, and
passaged on 1% gelatin-coated tissue culture plastic.
ECs were cultured in M199 (GIBCO, Rockville,
Md), supplemented with L-glutamine (2 mmol/L,
GIBCO), 10% fetal calf serum (Hyclone Labora-
tories Inc, Logan, Utah), heparin (150 µg/mL,
Sigma), penicillin and streptomycin (100 U/mL
and 100 mg/mL, respectively, GIBCO), and EC
growth supplement (50 µg/mL, Becton Dickenson,
Franklin Lakes, NJ). Cells were confirmed to be
endothelial by their standard morphologic appear-
ance, the presence of factor VIII–related antigen
(von Willebrand factor), and the specific uptake of
di-I-acetylated low density lipoprotein (Biomedical
Technologies Inc, Stoughton, Mass). These criteria
have also been used to assess whether ECs retain dif-
ferentiated characteristics in experimental cultures.
Silicone rubber tubes were first ultrasonically
cleaned, autoclaved, and placed in the tube holder.
The surface of the tubes was then coated with
fibronectin (0.01%; Collaborative Research Inc,
Bedford, Mass) overnight to enable the attachment
of ECs. Human umbilical vein endothelial cells (pas-
sage 2 through 4) were seeded at a confluent densi-
ty of 105/cm2, and the tube holder was rotated slow-
ly to ensure uniform luminal cell seeding. After 24
hours’ incubation, cells were examined visually with
an inverted phase contrast microscope. The system
was set up, and ECs were cultured in VFS and sub-
jected to the above experimental conditions. Serum-
free medium was used during the experimental peri-
od (M199, supplemented with 2 mmol/L L-gluta-
mine and 1% ITS liquid media supplement [Sigma]).
Dextran (Sigma) was used to increase viscosity of the
medium. At the end of each experiment, tubes were
examined with phase contrast microscopy and pho-
tographed. The tubes were gently rinsed twice with
Hank’s balanced salt solution (GIBCO). Trypsin-
EDTA (0.05%, GIBCO) was applied, and the
detaching cells were monitored at room temperature
under microscopy. An aliquot of cell counts with try-
pan blue exclusion gave a viability of more than 90%
in all the experiments performed. Cell pellets were
stored at –80°C until they were used.
Northern blot analysis. Northern hybridization
analysis was used to assay for gene induction associat-
ed with elevated flow or vessel collapse. Following
standard procedures,22 we isolated total RNA from
guanidine isothiocyanate extracts of experimental and
control silicone rubber tube cultures by centrifuga-
tion through cesium chloride, then separated by 1.2%
formaldehyde agarose gel electrophoresis, transferred
to nylon membranes, and hybridized in the presence
of 49% formamide, at 42°C, to specific 32P-labeled
tissue plasminogen activator (tPA), plasminogen acti-
vator inhibitor type 1 (PAI-1), annexin II, eNOS, and
endothelin-1 complementary DNA probes. The
autoradiographs on a Kodak X-OMAT AR x-ray film
(Eastman Kodak Co, Rochester, NY) were obtained
and quantitated by means of laser scanning densitom-
etry (Molecular Dynamics, Sunnyvale, Calif) with
Image Quant 3.0 software. The intensity of glycer-
aldehyde-3-phosphate dehydrogenase (GAPD) band
in each lane was used for normalization to correct any
differences in RNA loading.
Statistical analysis. The results are reported as
means ± SEM. The Student paired t test was used to
determine the levels of significance.
RESULTS
The experimental conditions specified previously
were achieved in the VFS to mimic conditions expe-
rienced in vivo during EPC (Table III). Typical flow
and pressure traces are shown in Fig 2. Each square-
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shaped pressure pulse generated by the air pump is
followed by a surge of increased flow rate. Flow
accelerates quickly, reaches and then maintains a
constant peak flow rate (12.5 mL/s), then returns
to a relatively long period (approximately 56 sec-
onds) of zero flow when the pressure is dropped to
zero. This type of flow is similar to that associated
with the application of an EPC to the lower leg.16
Shear stress calculated from measured flow is plotted
in Fig 2, which shows that the shear stress trace
essentially follows the flow trace with a peak level of
40 dyne/cm2.
ECs are also subjected to deformation when tubes
are compressed. The finite element simulation of the
wall strain by ABAQUS is plotted in Fig 3. The ves-
sel wall strain varies from 0% to 10% when the tube is
compressed by 50%, as shown in the figure.
All experimental monolayers were examined with
phase contrast microscopy before and after the
experiment. In both experimental and control tubes,
the ECs remained attached and viable after subject-
ed to intermittent pulsatile flow and tube compres-
sion (Fig 4). In general, with high flow (F and FC),
cells aligned in the direction of flow after 6 hours in
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Table III. Conditions used in the present experi-
ments
Parameter Value
Medium viscosity 0.04 cP, same as blood
Maximal flow rate (F and FC only) 12.5 mL/s
Peak shear stress F: 40 dyne/cm2; FC:
approximately 80 
dyne/cm2
Duration of maximal flow 4 s
Period of each cycle 60 s
Degree of tube compression Major diameter 
(C and FC only) reduced by 50%
Duration of experiment 1 or 6 hr
Fig 2. Measured pressure (top) flow rate (middle), and calculated shear stress (bottom) in the VFS for
condition F. Measurements are made at the locations indicated in Fig 1, A. Shear stress is calculated with
the Womersley theory,20 which is based on measured time-varying flow rate.
all circuits (Fig 4, A, C). Alignment was most promi-
nent with FC, but was never observed in the C and
Control groups (Fig 4, B, D).
Northern blot analysis of messenger RNA
(mRNA) expression of tPA and eNOS after a 6-hour
experiment is shown in Fig 5. Changes in the level of
expression relative to the control group and measured
with laser densitometry are summarized in Table IV.
There is an upregulation of tPA expression by a factor
of 1.95 ± 0.19 in F tubes, and the elevation in FC is
even greater than F group with a factor of 2.45 ±
0.46. eNOS expression is increased by a factor of 2.08
± 0.25 in F tubes and of 2.11 ± 0.21 in FC tubes.
Compression of the tube slightly upregulates tPA
expression (not significantly) but causes no detectable
change in eNOS expression. Gene expression for PAI-
1, annexin II, and endothelin-1 show no significant
changes under any of these experimental conditions
(Table IV; Northern blot images not shown).
DISCUSSION
The antithrombotic efficacy of an EPC device is
well documented throughout medical literature.5,23
Despite the widespread use of these devices, remark-
ably little is known of the precise mechanism of
action. In addition to the hemodynamic effect of
EPC, enhancement of fibrinolysis has been postulat-
ed to be important.24,25 However, whether there is
an enhancement of fibrinolysis is still under debate.
Jacob et al26 found that EPC causes significant
changes in systemic fibrinolysis. Conversely, in
O’Brien et al’s study,27 no difference in postoperative
fibrinolysis was observed between the control and
compression groups. Because the fundamental mech-
anisms of EPC have yet to be clearly delineated, the
optimal mode of compression (eg, timing, pressure
levels, cuff design) have yet to be established.
No good experimental model currently exists to
address these issues. Clinical studies are complicated
by population heterogeneity and clinical variables
that make interpretation of data extremely difficult.
Our goal is to better understand the mechanisms of
EPC with the use of a simple in vitro system in
which the relevant variables can be closely con-
trolled. In this article, we have described the design
and characteristics of a cell culture system to simu-
late mechanical forces encountered by vascular wall
cells during external leg compression. We have char-
acterized the apparatus with respect to its biome-
chanical and hemodynamic properties, including
compliance, wall thickness, flow, viscosity, and shear
stress level. The VFS has been proved to support the
EC culture, both morphologically and functionally.
In addition to regulating fibrinolysis and coagu-
lation, endothelium plays a significant role in the
regulation of vascular tone, inhibition of smooth
muscle cell growth, and platelet activation, and acts
as a mediator of the body’s inflammatory and
immunologic responses. Many of these functions
appear to be modulated by biomechanical forces.
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Fig 3. Color contour map showing calculated tube wall strain computed with finite element code
ABAQUS and properties of silicon rubber. Note that maximal principal strains range between 0% and
10%. ECs cultured in the inner layer of tube are subjected to same level of deformation. Note that at
upper and lower walls of tube, cells are stretched by about 10%.
However, few in vitro studies have addressed the
true complex nature of these forces or their poten-
tial clinical relevance. In general, vascular ECs have
been cultured on flat surfaces and subjected to shear
stress in parallel plate flow chambers or in cone plate
viscometers. In other studies, ECs grown on a flex-
ible flat surface have been subjected to cyclic strain.
The VFS is the first three-dimensional in vitro
device to simulate hemodynamic conditions that
result from intermittent external compression. It
JOURNAL OF VASCULAR SURGERY
984 Dai et al November 2000
Fig 4. Endothelial morphology after 6 hours of experiment. Flow direction is left to right in each pho-
tograph. Alignment is strongest in FC and F and cannot be detected in C or Cntrl (magnification =
200×). Cntrl, Control.
Table IV. Changes of gene expression in experimental groups relative to control levels
FC C F
tPA (n = 3) 2.45 ± 0.46* 1.34 ± 0.26 1.95 ± 0.19†
PAI-1 (n = 2) 1.30 ± 0.05 1.19 ± 0.12 1.26 ± 0.08
Annexin II (n = 2) 1.17 ± 0.14 1.33 ± 0.22 1.12 ± 0.09
eNOS (n = 3) 2.11 ± 0.21† 1.17 ± 0.29 2.08 ± 0.25*
Endothelin-1 (n = 2) 0.82 ± 0.06 0.97 ± 0.13 1.08 ± 0.05
*P < .05.
†P < .01.
provides a means of subjecting cultured ECs to the
isolated or combined effects of hemodynamic shear,
wall strain, and vessel collapse. The system permits
experimental control of the multiple parameters to
which these cells are exposed (eg, the timing cycle of
intermittent compression, peak shear stress level,
and duration of flow), which makes it possible to
systematically examine the relationship between
mechanical forces and endothelial functions. In this
initial set of experiments, the timing and pulsatile
flow rate are selected to represent a typical commer-
cial EPC device. However, the purpose of our study
is not merely to reproduce a single set of flow con-
ditions, but rather to develop an in vitro method
that would allow us to simulate a wide range of con-
ditions to find those that produce the optimal fibri-
nolytic response. Once these conditions are found,
then the computational model developed by our
group16 could be used to determine the external
compression parameters that might produce them.
Ultimately, clinical studies would be needed to
prove that the optimal mode of compression
obtained with this approach will actually improve
the clinical outcome.
Our initial results indicate that cells elongate and
align in the direction of flow after 6 hours in circuits
with high flow (F and FC), whereas cells cultured in
low-flow circuits C and Control) are not elongated
and are more randomly orientated. Scanning elec-
tron microscopy of blood vessels have shown that in
areas of uniform laminar flow in vivo, ECs exhibit an
ellipsoidal shape and align in the direction of
flow.28,29 Therefore, the aligned cells in our system
more closely mimic the morphology of endothelium
in vivo, suggesting, perhaps, a more general similar-
ity in functionality.
Our results show that after 6 hours’ incubation,
both tPA and eNOS mRNA expression are upregu-
lated by flow, whereas PAI-1, annexin II, and
endothelin-1 show no response to flow or vessel
strain. This suggests that hemodynamic conditions
generated by EPC enhance EC fibrinolytic and vaso-
motor function. Increased levels of tPA can decrease
the baseline level of fibrin formation, which might
contribute to the decreased incidence of DVT.
Upregulation of eNOS suggests increased nitric oxide
production, causing vasodilation and inhibiting
platelet adhesion and aggregation. Although we can-
not conclude that increased tPA and eNOS mRNA
observed in our system reflects increased protein pro-
duction, in several studies30,31 upregulation of tPA
and eNOS mRNA was found to be associated with
increased protein. The even greater increase of tPA
mRNA in FC than in F may be the result of higher
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Fig 5. Northern Blot of mRNA expression of tPA, eNOS, and GAPD (top to bottom). Lane 1-4 (left to
right) represents FC, C, F and Control group, respectively.
shear, because when the tube is compressed, cross
section area decreases, and shear stress will be much
higher than before compression for the same level of
flow. This situation mimics what happens in the vicin-
ity of the knee, where the veins are partially collapsed
while at the same time, they must convey the blood
being discharged from the calf. Our previous compu-
tational studies have shown that shear stress at this
location can exceed 150 dyne/cm2. The increased
tPA mRNA response seen in these experiments under
highly pulsatile flow on a 1-minute cycle is surpris-
ingly similar to results from previous studies with
steady shear stress. 
Of particular note is the result that in compression
only (C), there is little or no change in any of the
genes considered. In FC and F, similar trends of
upregulation are seen in tPA and eNOS, which sug-
gest that it is pulsatile shear stress, not vessel compres-
sion, that is responsible for these changes. This has
important implications for the design of EPC systems;
the objective should be to increase shear stress above a
certain level rather than to achieve vessel collapse. For
example, in our previous studies,16 both anterior-pos-
terior compression and circumferentially uniform
compression at 50 mm Hg generated the same degree
of vessel collapse and vessel wall strain; however, the
difference in shear stress level was considerable. 
These studies did not consider the possibility of
a tPA response at times less than 1 hour. In some
clinical studies,26 compression was found to induce
prompt and specific increases in fibrinolytic func-
tion. Fibrinolytic activity decays rapidly once com-
pression has been stopped, which is in conflict with
Knight and Dawson,32 who noted a persistent
enhancement of fibrinolytic activity up to 18 hours
after cessation of compression. Our in vitro cell cul-
ture system should provide some insight into this
problem. Experiments designed specifically to inves-
tigate the time scales for initiation and decay of the
response are in progress.
In this initial set of experiments, only a small seg-
ment of the fibrinolytic and vasomotor pathways are
considered. We know from numerous other studies,
however, that endothelial actively regulates many
aspects of hemostasis, all of which might be important
in the mechanisms of prophylaxis against DVT by
EPC. In the future, we plan to use this system to eval-
uate the effects of combined fluid shear and strain on
ECs over the range of biomechanical and hemody-
namic conditions encountered in vivo. Once the rela-
tionships between mechanical forces and endothelial
fibrinolytic activity, vasomotor function, and as many
other thromboregulation factors have been clearly
established, this information will provide a useful guide
in the design of an optimal mode of compression.
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Dr Robert W. Hobson II (Newark, NJ). Why do you
study EPC?
Dr Olga Tsukurov. We believe that there is room for
improving prophylactic treatment with external pneumatic
compression if it is to define optimal level of shear stress,
duration, and mode of cycle during when it is applied. Those
are questions we are going to address in our future work.
Dr Hobson. Did you check experience of the same fac-
tors under lower levels of shear stress and levels corre-
sponding to venous circulation?
Dr Tsukurov. We looked at expression of the same fac-
tors presented in the talk at lower levels of shear stress, 20
and 10 dyne/cm2, and did not detect changes comparing
to control. Our control represents shear stress levels for a
medium-size vein.
Dr Hobson. Why did you use such high levels of shear
stress in your experiment?
Dr Tsukurov. Our initial experiment is done at levels of
shear stress of 80 and 40 dyne/cm2 because those levels
were defined by computational model and finite element
analysis as shear stress levels generated during external
pneumatic compression. 
Dr Hobson. Omental endothelial cells have higher
expression of tissue plasminogen activator. Why did you
not use them in your experiment?
Dr Tsukurov. Human umbilical endothelial cells are
phenotypically closest to venous endothelial cells. That is
why we use them in our model.
Dr Hobson. Why do you think that NO is important
on the venous side?
Dr Tsukurov. Nitric oxide was reported to inhibit syn-
thesis and release of surface adhesion molecules (Seminars
in vascular surgery. Vol. 11, no. 3. 1998. p. 156-68),
which is important for endothelial fibrinolytic and
antithrombotic functions. That is why we looked at
expression of endothelial nitric oxide synthase, also. We
found an increase of eNOS expression in our experiment,
and in our further studies not reported here, we detected
an increase in NO release from endothelium under our
experimental conditions.
DISCUSSION
